SARS-CoV-2 Nucleocapsid Protein (Omicron B.1.1.529 Variant)

260€ (50 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
SARS-CoV-2 Nucleocapsid Protein (Omicron B.1.1.529 Variant)
category
Proteins and Peptides
provider
Abbexa
reference
abx620093
tested applications
SDS-PAGE
Description
SARS-CoV-2 Nucleocapsid Protein (Omicron B.1.1.529 Variant) is a recombinant protein expressed in E. coli.
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Proteins and Peptides |
Immunogen Target | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein (Omicron B.1.1.529 Variant) |
Host | E. coli |
Origin | Virus |
Observed MW | Molecular Weight: Calculated MW: 46.31 kDa Sequence Fragment: Met1-Ala419 Tag: N-terminal His tag |
Expression | Recombinant |
Purity | > 90% (SDS-PAGE) |
Size 1 | 50 µg |
Size 2 | 100 µg |
Size 3 | 1 mg |
Tested Applications | SDS-PAGE |
Buffer | Prior to lyophilization: PBS, pH 7.5, 0.02 % NLS, 1mM EDTA, 4 % Trehalose, 1 % Mannitol |
Availability | Shipped within 5-10 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
NCBI Accession | UFO69279.1 |
Background | Protein SARS-CoV-2 |
Status | RUO |
Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
Related Products

Human anti-SARS-CoV2 (N) IgG ELISA Kit
Ver Producto
Human anti-SARS-CoV2 (N) IgM ELISA Kit
Ver Producto